Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 5:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 649–672 of 995 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Comparison control condition Clear all

Conditions: Hypertension (HTN)
Interventions: Aktiia G1 BP monitor for 12 months, Traditional BP monitor for 6 months / Aktiia G1 BP monitor for 6 months; Device
Lead sponsor: Aktiia SA; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Unspecified Child Maltreatment, Suspected, Unspecified Child Maltreatment, Confirmed
Interventions: Durham Connects; Other
Lead sponsor: Duke University; Other
Eligibility: Up to 6 Months
Enrollment: 1,650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Human Papilloma Virus, Vaccine-Preventable Diseases
Interventions: HPV Twitter Education Program - Narrative, HPV Twitter Education Program - Non-Narrative; Other
Lead sponsor: University of Arkansas, Fayetteville; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Prediabetes, Obesity
Interventions: Group-Based Lifestyle Intervention (Phases 1 and 2), Individual Education Program (All Phases), Self-Directed Maintenance (Phase 3), Extended Group Maintenance (Phase 3); Behavioral · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years and older
Enrollment: 301 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Crohn's Disease (CD), Ulcerative Colitis (UC)
Interventions: Vitamin D3; Dietary Supplement
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Fresno, California

Conditions: Anorexia Nervosa
Interventions: Quetiapine, Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Anxiety, Panic Disorder
Interventions: Freespira Breathing System; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 9 Years to 17 Years
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cancer
Interventions: protein expression analysis, immunohistochemistry staining method, laboratory biomarker analysis, biopsy; Genetic · Other · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: Up to 120 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Depression, Anxiety
Interventions: Quetiapine-XR; Drug
Lead sponsor: Loyola University; Other
Eligibility: 20 Years to 65 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Opioid Users
Interventions: Capsule, PF-00345439, oxycodone; Drug
Lead sponsor: Pain Therapeutics; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Fundamental Adaptive Skills Training, Relaxation and Mindfulness Training
Interventions: Fundamental Adaptive Skills Training, Relaxation and Mindfulness Training; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Lung Cancer
Interventions: Engaged Approach to Lung Cancer Screening; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Depressive Disorder, Major
Interventions: GW856553, Placebo; Drug · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 4
States / cities: Hoffman Estates, Illinois • Park Ridge, Illinois • New York, New York + 1 more

Conditions: Type 2 Diabetes, PreDiabetes
Interventions: Project Health, Educational Video Control; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Kidney Failure, Chronic, Anemia, Iron-Deficiency
Interventions: iron sucrose injection, USP, sodium ferric gluconate complex in sucrose injection; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 12
States / cities: Phoenix, Arizona • Alhambra, California • Bell Gardens, California + 9 more

Conditions: Type 1 Diabetes
Interventions: MRI, US, and blood samples; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 8 Years to 45 Years
Enrollment: 246 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Complicated Skin and Skin Structure Infections
Interventions: JNJ-32729463, linezolid, JNJ-32729463 placebo, linezolid placebo; Drug
Lead sponsor: Furiex Pharmaceuticals, Inc; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 27
States / cities: Anaheim, California • Buena Park, California • Chula Vista, California + 23 more

Conditions: Smoking, Nicotine Dependence, Mental Disorders
Interventions: Cognitive / Motivational Individual Sessions, Attention Control Individual Sessions, Nicotine Patch, Group Curriculum; Behavioral · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 99 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Nightmares
Interventions: ERRT-M for Nightmares; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 65 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Fort Hood, Texas

Conditions: COPD
Interventions: indacaterol, placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 40 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 6
States / cities: Fullerton, California • Saint Charles, Missouri • Charlotte, North Carolina + 3 more

Conditions: Stage IV Pancreatic Cancer
Interventions: Gemcitabine, PEGPH20, Placebo; Drug
Lead sponsor: Halozyme Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 8
States / cities: Fayetteville, Arkansas • San Francisco, California • Indianapolis, Indiana + 5 more

Conditions: Covid19
Interventions: Metformin, Naltrexone; Drug
Lead sponsor: AgelessRx; Industry
Eligibility: 30 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Instructional Methods
Interventions: Conceptual teaching; Other
Lead sponsor: Sentara Norfolk General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Opioid Use Disorder, Sleep, Circadian Rhythms, fMRI Research
Interventions: AYO light glasses (experimental), AYO light glasses (comparator); Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 60 Years
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control

Durham Connects RCT Evaluation II

Hashtag HPV: HPV Vaccine Twitter Education Program

Healthy Living Partnership to Prevent Diabetes

Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D

Trial of Quetiapine in Anorexia Nervosa

The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety Patients

Abuse Potential Study of PF-00345439

The Fundamental Adaptive Skills Training

Testing the Engaged Approach to Lung Cancer Screening

Clinical Study to Test a New Drug to Treat Major Depression

Evaluating a Type 2 Diabetes Prevention Program

Comparison Between Effects of Two Iron Preparations on Protein in the Urine

Pancreas Volume in Preclinical Type 1 Diabetes

Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)

Helping Those With Mental Illness Quit Smoking

A Trial of Treatment for Trauma-Related Nightmares in Active Duty Military Personnel

Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer

Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19

A Study to Evaluate Strategies for Teaching Effective Use of Diagnostic Tests

The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD)